Camlin Fine Sciences Ltd
NSE: CAMLINFINE BSE: 532834
Camlin Fine Sciences Ltd (CAMLINFINE) is a Diversified company listed on NSE: CAMLINFINE | BSE: 532834. With a market cap of ₹2,301 Cr and ROCE of 3.75%, ROE of 2.33%, it operates in the Indian Diversified sector.
₹120
52W: ₹96.2 — ₹335
PE 1354 · Book ₹44 · +173% vs bookMarket Cap₹2,301 Cr
Stock P/E1354Price to Earnings
ROCE3.75%Return on Capital
ROE2.33%Return on Equity
Div. Yield0%Face Value ₹1
Strengths
- +Debtor days have improved from 215 to 171 days.
Weaknesses
- −Stock is trading at 2.74 times its book value
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of 8.86% over past five years.
- −Company has a low return on equity of 0.82% over last 3 years.
- −Company has high debtors of 171 days.
Shareholding Pattern
Promoters48.03%
FIIs0.94%
DIIs7.7%
Public43.31%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 48.03% | 48.03% | 48.03% | 49.09%▲1.1 | 49.09% | 49.08%▼0.0 | 48.03%▼1.0 | 48.03% |
| FIIs | 1.01% | 0.81%▼0.2 | 0.76%▼0.1 | 1.47%▲0.7 | 2.88%▲1.4 | 2.11%▼0.8 | 2.12%▲0.0 | 0.94%▼1.2 |
| DIIs | 4.88% | 4.23%▼0.6 | 3.38%▼0.9 | 3.83%▲0.5 | 4.14%▲0.3 | 5.48%▲1.3 | 7.77%▲2.3 | 7.7%▼0.1 |
| Public | 46.07% | 46.93%▲0.9 | 47.83%▲0.9 | 45.61%▼2.2 | 43.88%▼1.7 | 43.33%▼0.6 | 42.07%▼1.3 | 43.31%▲1.2 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 206 | 186 | 220 | 182 | 227 | 205 | 273 | 191 | 244 | 219 |
| Expenses | 185 | 180 | 246 | 175 | 213 | 189 | 239 | 187 | 226 | 200 |
| Operating Profit | 21 | 6 | -26 | 7 | 14 | 16 | 33 | 5 | 18 | 19 |
| OPM % | 10% | 3% | -12% | 4% | 6% | 8% | 12% | 2% | 7% | 9% |
| Net Profit | -1 | -12 | -44 | -14 | -73 | -6 | 16 | -11 | -4 | -13 |
| EPS ₹ | -0.08 | -0.62 | -2.35 | -0.73 | -3.86 | -0.3 | 0.83 | -0.57 | -0.19 | -0.68 |
AI Insights
Revenue Trend
TTM revenue at ₹927Cr, up 4.6% YoY. OPM at 8%.
Debt Position
Borrowings at ₹420Cr. Debt-to-equity ratio: 0.51x. Moderate leverage.
Capex Cycle
CWIP at ₹13Cr (2% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 7.7% (-1.61pp change). FIIs: 0.94% (-9.17pp change). Promoters hold 48.03%.
Margin & Efficiency
ROCE declining from 28% (Mar 2014) to 4% (Mar 2025). Working capital days: 94.
Valuation
PE 1354x with 3.75% ROCE. Price is 173% above book value of ₹44. Dividend yield: 0%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 2d - Monitoring agency report for March 31, 2026 rights issue shows 100% proceeds utilized; no deviation.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 8 May - Members approved increase in authorized share capital via postal ballot on May 7, 2026.
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 8 May - Members approved increase in authorized share capital via postal ballot on May 7, 2026.
- Press Release Issued By The Company. 4 May - Camlin files mandatory tender offer for remaining Vinpai shares at EUR 3.60 on May 4, 2026.
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 21 Apr - Promoter Ashish Dandekar released pledge on 8,00,000 and 32,96,000 shares on April 10 and 17, 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse